Search - tctmd.com

Displaying 601 - 620 of 1123

Sort: Relevancy | Date

Presentation TCT 2016

Treatment of Bifurcation Stenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Treatment of Chronic Total Occlusions

Presenter: Teguh Santoso, Wasan Udayachalerm, Naoki Masuda

October 30, 2016

Presentation TCT 2016

Current Generation DES and Bioabsorbable Scaffolds

Presenter: Dmitriy N. Feldman, Rajesh V Swaminathan

October 30, 2016

Presentation TCT 2016

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Presenter: Mohamed Abdel-Wahab, Philippe Généreux, Manuel Pan

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Azeem Latib

October 30, 2016

Presentation TCT 2016

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More

Presenter: Koen Deloose, Jihad A. Mustapha

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

Case Presentations: How to Use IVUS to Optimize Bioresorbable Scaffold Implantation

Presenter: Antonio Colombo, Gary S. Mintz

October 30, 2016

Presentation TCT 2016

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Runlin Gao

October 30, 2016

Presentation TCT 2016

Case Presentations: How to Deploy a Bioresorbable Scaffold With OCT. Preintervention and Postintervention Information

Presenter: Akiko Maehara, Francesco Prati, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Ashok Seth

October 30, 2016

Presentation TCT 2016

Keynote Lecture: Enter the Bioresorbable Scaffold Era: Similarities and Differences From Metallic DES

Presenter: Thomas H. Maloney, Azeem Latib

October 29, 2016

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2016

Ankur Kalra

October 27, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

L.A. McKeown

September 22, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Opinion Fellow Talk

Top 10 Tricks for Choosing the Right Stent

Yael L. Maxwell

August 20, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

Advertisement

Treatment of Bifurcation Stenosis

Treatment of Chronic Total Occlusions

Current Generation DES and Bioabsorbable Scaffolds

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: How to Use IVUS to Optimize Bioresorbable Scaffold Implantation

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: How to Deploy a Bioresorbable Scaffold With OCT. Preintervention and Postintervention Information

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Keynote Lecture: Enter the Bioresorbable Scaffold Era: Similarities and Differences From Metallic DES

My Picks for Fellows Attending TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Top 10 Tricks for Choosing the Right Stent

The Bioresorbable Stent Story So Far: What Promise? What Price?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content